Drug recall · July 11, 2018
Neostigmine Methylsulfate Injection Solution recall
Why: Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile Services, ICB Laboratories, 8710 E 34th St. N., Wichita, KS 67205, NDC 71266-2003-02.
- Lots / codes
Lot #: C274-000004690, BUD: 09/21/18.
- Quantity
- 840 prefilled syringes
- Company
- Fagron Compounding Services LLC dba Fagron Sterile Services, Wichita, KS
- Distribution
- Nationwide in the USA
- Initiated
- June 29, 2018 · Voluntary: Firm initiated
- Classified
- July 6, 2018
- Reported
- July 11, 2018
- Ended
- August 31, 2020
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Neostigmine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.